EXHIBIT 99.1

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value, of Alzamend Neuro, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

 

Dated: April 28, 2022

 

    BITNILE HOLDINGS, INC.

/s/ Milton C. Ault, III

     
MILTON C. AULT, III   By:

/s/ Milton C. Ault, III

      Name: Milton C. Ault, III
      Title: Executive Chairman

 

    AULT LIFE SCIENCES, INC.

/s/ William B. Horne

     
WILLIAM B. HORNE   By:

/s/ Milton C. Ault, III

      Name: Milton C. Ault, III
      Title: Chief Executive Officer

 

    AULT LIFE SCIENCES FUND, LLC

/s/ Henry C.W. Nisser

     
HENRY C.W. NISSER   By:

/s/ Milton C. Ault, III

      Name: Milton C. Ault, III
      Title: Managing Member

 

    AULT ALPHA LP

/s/ Kenneth S. Cragun

     
KENNETH S. CRAGUN   By:

/s/ Milton C. Ault, III

      Name: Milton C. Ault, III
      Title: Manager of Ault Alpha GP LLC, the general partner

 

    DIGITAL POWER LENDING, LLC

/s/ David J. Katzoff

     
DAVID J. KATZOFF   By:

/s/ David J. Katzoff

      Name: David J. Katzoff
      Title: Manager